---
title: "Boston Scientific Corporation (BSX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BSX.US.md"
symbol: "BSX.US"
name: "Boston Scientific Corporation"
industry: "Health Care Equipment"
datetime: "2026-05-20T03:06:48.327Z"
locales:
  - [en](https://longbridge.com/en/quote/BSX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BSX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BSX.US.md)
---

# Boston Scientific Corporation (BSX.US)

## Company Overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.bostonscientific.com](https://www.bostonscientific.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: B (0.32)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 5 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 17.43% |  |
| Net Profit YoY | 75.44% |  |
| P/B Ratio | 3.21 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 83116981609.68 |  |
| Revenue | 20614000000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 14.83% | A |
| Profit Margin | 17.29% | A |
| Gross Margin | 69.21% | A |
| Revenue YoY | 17.43% | B |
| Net Profit YoY | 75.44% | A |
| Total Assets YoY | 10.49% | B |
| Net Assets YoY | 16.30% | B |
| Cash Flow Margin | 121.77% | B |
| OCF YoY | 17.43% | B |
| Turnover | 0.49 | C |
| Gearing Ratio | 41.14% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Boston Scientific Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "17.43%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "75.44%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.21",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "83116981609.68",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "20614000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "14.83%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "17.29%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "69.21%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "17.43%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "75.44%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "10.49%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "16.30%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "121.77%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "17.43%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.49",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "41.14%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 23.69 | 25/183 | 63.42 | 53.25 | 36.82 |
| PB | 3.26 | 80/183 | 6.90 | 6.31 | 4.40 |
| PS (TTM) | 4.10 | 85/183 | 8.52 | 7.64 | 5.31 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **33**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 23 | 70% |
| Overweight | 8 | 24% |
| Hold | 2 | 6% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 56.81 |
| Highest Target | 110.00 |
| Lowest Target | 60.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BSX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BSX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/BSX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BSX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**